|Day Low/High||300.50 / 314.28|
|52 Wk Low/High||187.72 / 310.12|
We see a notable shift away from traditional large-cap pharmaceutical stocks to more specialized niches.
I have never seen anything like the beast that is rocking this market.
The four dichotomies gravitate towards the bulls, not the bears.
It might look easy now, but it looked easy in 1999, too.
If you purchased Bitcoin one month ago today, you are now down heavily on your investment.
Wondering what you need to know as Wall Street heads back to work after a long weekend? You might want to be ready for Dow 26,000...
Monster ranked the companies that did the most hiring in 2017. Wonder who they are? Watch our video!
Mark Bertolini's stock options total in the hundreds of millions of dollars.
Here's what you need to know as Wall Street heads into midday trading.
UnitedHealth leads Dow higher but Autodesk drags on the Nasdaq and S&P 500.
What to do when the market gets choppy as hundreds of companies report results.
Treasury secretary says it's baked into the market, but is anyone really counting on it?
There's a case to be made for underpricing, even in this market.
"Everyone is putting money in the market, so you might as well follow." -- CNBC talking head In the aggregate, the markets were uneventful -- with another remarkably narrow range in the S&P Index. But there were some major movers. On the upside,...
Positive earnings from UnitedHealth Group and Johnson & Johnson sweep the Dow Jones Industrial Average to top 23,000 and hit a new all-time high.
Today's top stories: NFL owners gather today to talk about the players standing during the National Anthem, UnitedHealth earnings were released, Netflix has added more subscribers.
The government situation is still in flux - be careful with United Healthcare.
Healthcare stocks lagged Friday following the President's actions against Obamacare.
Events that would normally give investors pause have merely primed the pump.
Teva could be on the verge of a surge similar to what 3 other companies have seen since 2008-09.
Hear me out: The same lessons and disciplines are useful in both.
UNH continues to rise, and we have a new price target and stop level.
Let's see if the upward moves of these 10 stocks are merited.
It's difficult for even the best companies to resist infection.